BackParatek Pharmaceuticals Overview

Paratek Pharmaceuticals Operating Income

Operating Income for PRTK.

Quarterly Operating Income

$-9411000.00
28.53% YoY

As of Jun 30, 2023

Annual Operating Income (TTM)

$-44544000.00
34.38% YoY

Trailing 12 months ending Jun 30, 2023

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)